Half Yearly Results Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Mar'21
Sep'20
Net Sales
29.10
21.94
Other Operating Income
0.00
0.00
Total Operating income
29.10
21.94
Raw Material Cost
25.36
19.38
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
Employee Cost
0.52
0.62
Power Cost
0.00
0.00
Manufacturing Expenses
0.38
0.21
Selling and Distribution Expenses
3.39
1.84
Other Expenses
-0.90
-0.83
Total Expenditure (Excl Depreciation)
28.75
21.22
Operating Profit (PBDIT) excl Other Income
0.35
0.73
Other Income
0.01
0.01
Operating Profit (PBDIT)
0.72
0.95
Interest
0.38
0.21
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
3.74
2.56
Depreciation
0.36
0.21
Profit Before Tax
-0.02
0.52
Tax
-0.00
0.14
Provisions and contingencies
0.00
0.00
Profit After Tax
-0.02
0.39
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
-0.02
0.39
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
-0.02
0.39
Equity Capital
0.00
0.00
Face Value
10.0
10.0
Reserves
15.65
16.28
Earnings per share (EPS)
-0.0
0.06
Diluted Earnings per share
-0.0
0.06
Operating Profit Margin (Excl OI)
1.19%
3.31%
Gross Profit Margin
1.18%
3.36%
PAT Margin
-0.05%
1.77%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Mar 2021 is 32.63%
Consolidate Net Profit
Growth in half year ended Mar 2021 is -105.13%
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Mar 2021 is -24.47%
Interest
Growth in half year ended Mar 2021 is 80.95%
Operating Profit Margin (Excl OI)
Growth in half year ended Mar 2021 has fallen from Sep 2020
Compare Half Yearly Results Of Ajooni Biotech With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
29.10
0
29.10
Other Operating Income
0.00
0.00
0.00
Total Operating income
29.10
0
29.10
Raw Material Cost
25.36
0
25.36
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.52
0
0.52
Power Cost
0
0
0.00
Manufacturing Expenses
0.38
0
0.38
Selling and Distribution Expenses
3.39
0
3.39
Other Expenses
-0.90
0.00
-0.90
Total Expenditure (Excl Depreciation)
28.75
0
28.75
Operating Profit (PBDIT) excl Other Income
0.35
0.00
0.35
Other Income
0.01
0
0.01
Operating Profit (PBDIT)
0.72
0
0.72
Interest
0.38
0
0.38
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
3.74
0
3.74
Depreciation
0.36
0
0.36
Profit Before Tax
-0.02
0
-0.02
Tax
-0.00
0
-0.00
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-0.02
0
-0.02
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-0.02
0
-0.02
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-0.02
0
-0.02
Equity Capital
0
0
0.00
Face Value
10.00
0
0.00
Reserves
15.65
0
15.65
Earnings per share (EPS)
-0.00
0
-0.00
Diluted Earnings per share
-0.00
0
-0.00
Operating Profit Margin (Excl OI)
1.19%
0%
0.00
1.19%
Gross Profit Margin
1.18%
0%
0.00
1.18%
PAT Margin
-0.05%
0%
0.00
-0.05%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 29.10 Cr
in Mar 2021Figures in Cr
Growth in half year ended Mar 2021 is 32.63%
Half Yearly - Consolidate Net Profit
Consolidate Net Profit -0.02 Cr
in Mar 2021Figures in Cr
Growth in half year ended Mar 2021 is -105.13%
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.71 Cr
in Mar 2021Figures in Cr
Growth in half year ended Mar 2021 is -24.47%
Half Yearly - Interest
Interest 0.38 Cr
in Mar 2021Figures in Cr
Growth in half year ended Mar 2021 is 80.95%
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.19%
in Mar 2021Figures in %
Growth in half year ended Mar 2021 has fallen from Sep 2020
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
